Sõpruse pst, 10615, Tallinn, Estonia +372-55650441
  1. Home
  2. Blog
Add Blog Entry RSS

Announcements

No announcements yet

New blog posts

54 Scopus-indexed documents in three years
54 Scopus-indexed documents in three years

30 October, 2026 by Charlotte Lee

Over the past three years, TULTECH’s research...

One Bad Trial, One Big Problem: How a Flawed Study Skewed Prozac Guidance for Children
One Bad Trial, One Big Problem: How a Flawed Study Skewed Prozac Guidance for Children

5 October, 2026 by Mehrdad Fathi

A single small clinical trial from 2006 may...

Can Pancreatic Cancer Be Stopped in Its Tracks? A Radical Tactic Raises Hopes
Can Pancreatic Cancer Be Stopped in Its Tracks? A Radical Tactic Raises Hopes

4 October, 2026 by Mehrdad Fathi

With prospects for new treatments at an...

View all blog entries →

Journals

 

 

Weather

Clouds

8°C

Clouds in Tallinn

Calendar of Events

Closest Events
All events on this day

Blog

Immune Therapy Engineered Inside the Body Eases Multiple Sclerosis

Immune Therapy Engineered Inside the Body Eases Multiple Sclerosis

autoimmune disease B cell depletion cancer immunology CAR-T cell therapy immunotherapy in vivo gene therapy lentiviral vector multiple sclerosis translational medicine

Posted on 7 September, 2026 by Mehrdad Fathi

For years, CAR-T-cell therapy has operated on a straightforward but labour-intensive logic: extract T cells from a patient, engineer them in a laboratory to target a specific molecule, and reinfuse them. It works. It has transformed outcomes in blood cancers. But it is slow, expensive, and operationally demanding in ways that limit who can access it and where. A clinical trial published this week in The New England Journal of Medicine tests a different premise: what if the genetic...
Who Is Responsible When AI Helps to Write Science?

Who Is Responsible When AI Helps to Write Science?

AI authorship AI in research generative AI open science research integrity scholarly publishing

Posted on 2 September, 2026 by Mehrdad Fathi

Generative AI is now embedded in the daily workflow of research. It summarizes literature, drafts sections, sharpens arguments, and increasingly shapes the conceptual framing of papers. Yet publishing norms have not kept pace. The question that remains unanswered is not whether AI is being used — it clearly is — but who is accountable for what it produces. Authorship was never just a credit mechanism. It is an accountability structure: a signal to the community that a named scholar stands...
A Personalized mRNA Cancer Vaccine Just Passed a Phase III Trial — Here’s What It Means

A Personalized mRNA Cancer Vaccine Just Passed a Phase III Trial — Here’s What It Means

cancer immunology immunotherapy intismeran melanoma Moderna mRNA cancer vaccine oncology pembrolizumab personalized medicine

Posted on 1 September, 2026 by Mehrdad Fathi

For decades, the idea of a vaccine that trains your immune system to fight your own tumour has been theoretically compelling and practically elusive. This week, that changed. Moderna and Merck announced that intismeran — a personalized mRNA cancer vaccine — reduced melanoma recurrence in a phase III clinical trial, marking the first time an mRNA-based cancer treatment has succeeded at this scale. The result doesn’t just matter for melanoma. It’s a proof-of-concept moment with implications...
AI-Detection Tools Have Made a Major Leap Forward — But Can They Be Trusted?

AI-Detection Tools Have Made a Major Leap Forward — But Can They Be Trusted?

academic publishing AI detection GPTZero large language models Pangram peer review research integrity scientific writing ethics

Posted on 31 August, 2026 by Mehrdad Fathi

When Daniel Evanko asked a scientist whether they had used artificial intelligence to write their peer-review report, he didn’t expect a confession. Most researchers don’t reveal AI help, says Evanko, who is the director of journal operations at the American Association for Cancer Research (AACR). But this time was different. “Wow, you guys are good!” the reviewer wrote back, admitting he had used a large language model (LLM) after running out of time. Evanko had a secret weapon: a...
Mapping Depression at Single-Cell Resolution: Why the Brain Struggles to Grow New Neurons

Mapping Depression at Single-Cell Resolution: Why the Brain Struggles to Grow New Neurons

adult neurogenesis brain mapping drug discovery hippocampus major depressive disorder mental health neuroscience research single-cell sequencing

Posted on 26 August, 2026 by Mehrdad Fathi

The brains of people with depression appear to be less capable of producing new neurons than those of people without the disorder. That is the headline finding of a study published in Nature Medicine , built on the most comprehensive map yet assembled of cell types in the adult human hippocampus — the brain region central to learning, memory and emotion. A Twenty-Year-Old Hypothesis Meets Modern Technology For more than two decades, some researchers have suspected that a disruption...
  • Page 4 / 9
  • 2
  • 3
  • 4
  • 5
  • 6

Event Categories

0 Conference 0 Symposium 4 Workshop

Past Events

Workshop on Artificial Intelligence Applications in Smart Cities
20 August, 2024
Workshop on Advanced Water Treatment Processes
10 July, 2024
Workshop On Solar System Simulations and Green Buildings
10 May, 2024
Workshop on Water Recycling Simulation and Modelling
15 March, 2024

Today In History

Here are some interesting facts ih history happened on 2 November.

  1. Cobblestone paving of Washington St between Dupont & Kearny starts
  2. North Dakota becomes 39th and South Dakota becomes the 40th state
  3. Lansing-Ishii Agreement
  4. The Balfour Declaration calls for a Jewish homeland
  5. KDKA (Pittsburgh) on the air as 1st commercial radio station
  6. Howard Hughes' Spruce Goose flies for 1st (& last) time
  7. Truman beats Dewey confounding pollsters and newspapers
  8. JS Thurmond 1st senator elected by write-in vote - SC
  9. 1st titanium mill opened Toronto Ohio
  10. Charles Van Doren confesses 21 was fixed
  11. CBS purchases NY Yanks
  12. Ed Giacomin return to Mad Sq Garden as a Red Wing beats Rangers 6-4
  13. Crew of Soyuz 29 returns to Earth aboard Soyuz 31
  14. Edith Bunker dies

Menu

About TULTECH

TULTECH (Talent under Liberty in Technology) is a non-profit organization dedicated to advancing education, research, knowledge, and responsible technological innovation for the benefit of society. Through research, academic publishing, educational activities, events, and technology development, we connect researchers, educators, students, and communities to share knowledge and create practical solutions to social, environmental, and technological challenges.

Mission

Our mission is to advance education, research, knowledge, and technological innovation for the benefit of society. Through research, publications, educational activities, events, and open technological solutions, TULTECH promotes accessible learning, interdisciplinary collaboration, social and environmental responsibility, and the responsible use of technology to create positive impact in communities.

Vision

TULTECH envisions a globally connected society where education, research, and technology are accessible and used responsibly to address social, environmental, and technological challenges. We aspire to contribute to a more inclusive, sustainable, knowledgeable, and innovative future.

 

Talent under Liberty in Technology (TULTECH):  EE472200221072318428